The latest study on Antivirals Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Antivirals Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Antivirals and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Merck
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma
Cipla
Dr Reddy s
Antivirals Market Analysis By Type Segment:
Generic
Branded
Antivirals Market Analysis By Application Segment:
Application I
HIV
Hepatitis
HSV
Influenza
Antivirals Market Analysis By Regions (Countries):
The Antivirals Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Antivirals Report:
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Antivirals Market:
Antivirals market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Antivirals Market status and future forecast.
To present the key Antivirals Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antivirals Market Size Growth Rate by Type (2016-2027)
1.3.2 Generic
1.3.3 Branded
1.4 Market Segment by Application
1.4.1 Global Antivirals Market Share by Application (2021-2027)
1.4.2 Application I
1.4.3 HIV
1.4.4 Hepatitis
1.4.5 HSV
1.4.6 Influenza
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antivirals Market Size
2.1.1 Global Antivirals Revenue 2016-2027
2.1.2 Global Antivirals Sales 2016-2027
2.2 Antivirals Growth Rate by Regions
2.2.1 Global Antivirals Sales by Regions 2016-2020
2.2.2 Global Antivirals Revenue by Regions 2016-2020
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Antivirals Sales by Manufacturers
3.1.1 Antivirals Sales by Manufacturers 2020
3.1.2 Antivirals Sales Market Share by Manufacturers 2020
3.2 Revenue by Manufacturers
3.2.1 Antivirals Revenue by Manufacturers (2020)
3.2.2 Antivirals Revenue Share by Manufacturers (2020)
3.2.3 Global Antivirals Market Concentration Ratio (CR5 and HHI)
3.3 Antivirals Price by Manufacturers
3.4 Key Manufacturers Antivirals Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antivirals Market
3.6 Key Manufacturers Antivirals Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Generic Sales and Revenue (2016-2020)
4.1.2 Branded Sales and Revenue (2016-2020)
4.2 Global Antivirals Sales Market Share by Type
4.3 Global Antivirals Revenue Market Share by Type
4.4 Antivirals Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Antivirals Sales by Application
6 United States
6.1 United States Antivirals Breakdown Data by Company
6.2 United States Antivirals Breakdown Data by Type
6.3 United States Antivirals Breakdown Data by Application
7 European Union
7.1 European Union Antivirals Breakdown Data by Company
7.2 European Union Antivirals Breakdown Data by Type
7.3 European Union Antivirals Breakdown Data by Application
8 China
8.1 China Antivirals Breakdown Data by Company
8.2 China Antivirals Breakdown Data by Type
8.3 China Antivirals Breakdown Data by Application
9 Rest of World
9.1 Rest of World Antivirals Breakdown Data by Company
9.2 Rest of World Antivirals Breakdown Data by Type
9.3 Rest of World Antivirals Breakdown Data by Application
9.4 Rest of World Antivirals Breakdown Data by Countries
9.4.1 Rest of World Antivirals Sales by Countries
9.4.2 Rest of World Antivirals Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Antivirals
10.1.4 Antivirals Product Introduction
10.1.5 Merck Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Antivirals
10.2.4 Antivirals Product Introduction
10.2.5 Johnson & Johnson Recent Development
10.3 Teva Pharmaceutical Industries
10.3.1 Teva Pharmaceutical Industries Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Antivirals
10.3.4 Antivirals Product Introduction
10.3.5 Teva Pharmaceutical Industries Recent Development
10.4 GSK
10.4.1 GSK Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Antivirals
10.4.4 Antivirals Product Introduction
10.4.5 GSK Recent Development
10.5 Mylan
10.5.1 Mylan Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Antivirals
10.5.4 Antivirals Product Introduction
10.5.5 Mylan Recent Development
10.6 Gilead Sciences
10.6.1 Gilead Sciences Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Antivirals
10.6.4 Antivirals Product Introduction
10.6.5 Gilead Sciences Recent Development
10.7 F. Hoffmann-La Roche
10.7.1 F. Hoffmann-La Roche Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Antivirals
10.7.4 Antivirals Product Introduction
10.7.5 F. Hoffmann-La Roche Recent Development
10.8 Bristol-Myers-Squibb
10.8.1 Bristol-Myers-Squibb Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Antivirals
10.8.4 Antivirals Product Introduction
10.8.5 Bristol-Myers-Squibb Recent Development
10.9 AbbVie
10.9.1 AbbVie Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Antivirals
10.9.4 Antivirals Product Introduction
10.9.5 AbbVie Recent Development
10.10 Aurobindo Pharma
10.10.1 Aurobindo Pharma Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Antivirals
10.10.4 Antivirals Product Introduction
10.10.5 Aurobindo Pharma Recent Development
10.11 Cipla
10.12 Dr Reddy s
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Antivirals Sales Channels
11.2.2 Antivirals Distributors
11.3 Antivirals Customers
12 Market Forecast
12.1 Global Antivirals Sales and Revenue Forecast 2021-2027
12.2 Global Antivirals Sales Forecast by Type
12.3 Global Antivirals Sales Forecast by Application
12.4 Antivirals Forecast by Regions
12.4.1 Global Antivirals Sales Forecast by Regions 2021-2027
12.4.2 Global Antivirals Revenue Forecast by Regions 2021-2027
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Antivirals Product Picture
Table Antivirals Key Market Segments
Table Major Manufacturers Antivirals Covered in This Report
Table Global Antivirals Market Size Growth Rate by Type 2021-2027 (K Units) & (Million US$)
Figure Global Antivirals Sales Market Shar by Type 2016-2027
Figure Generic Figures
Table Major Manufacturers of Generic
Figure Branded Figures
Table Major Manufacturers of Branded
Table Global Antivirals Market Share by Application 2021-2027 (K Units)
Figure Application I Use Case
Figure HIV Use Case
Figure Hepatitis Use Case
Figure HSV Use Case
Figure Influenza Use Case
Figure Antivirals Report Years Considered
Figure Global Antivirals Market Size 2016-2027 (Million US$)
Figure Global Antivirals Sales 2016-2020 (K Units)
Table Global Antivirals Market Size by Regions 2016-2020 (K Units) & (Million US$)
Table Global Antivirals Sales by Regions 2016-2020 (K Units)
Table Global Antivirals Sales Market Share by Regions 2016-2020
Figure Global Antivirals Sales Market Share by Regions 2016-2020
Figure Global Antivirals Sales Market Share by Regions in 2020
Table Global Antivirals Revenue by Regions 2016-2020 (Million US$)
Table Global Antivirals Revenue Market Share by Regions 2016-2020
Figure Global Antivirals Revenue Market Share by Regions 2016-2020
Figure Global Antivirals Revenue Market Share by Regions in 2020
Table Market Top Trends
Table Global Antivirals Sales by Manufacturers (2020) (K Units)
Table Global Antivirals Sales Share by Manufacturers (2020)
Figure Global Antivirals Sales Share by Manufacturers in 2020
Table Antivirals Revenue by Manufacturers (2020) (Million USD)
Table Antivirals Revenue Share by Manufacturers (2020)
Figure Antivirals Value Share by Manufacturers in 2020
Table Global Antivirals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Antivirals Price (2016-2020) (USD/Unit)
Table Key Manufacturers Antivirals Plants/Factories Distribution
Table Key Manufacturers Antivirals Area Served
Table Date of Key Manufacturers Enter into Antivirals Market
Table Key Manufacturers Antivirals Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Generic Sales and Revenue (2016-2020) (K Units) & (Million US$)
Table Global Branded Sales and Revenue (2016-2020) (K Units) & (Million US$)
Table Global Antivirals Sales by Type (2016-2020) (K Units)
Table Global Antivirals Sales Share by Type (2016-2020)
Figure Global Antivirals Sales Market Share by Type (2016-2020)
Figure Global Antivirals Sales Market Share by Type in 2020
Table Global Antivirals Revenue by Type (2016-2020) (Million US$)
Table Global Antivirals Revenue Share by Type (2016-2020)
Figure Global Antivirals Revenue Market Share by Type (2016-2020)
Figure Global Antivirals Revenue Market Share by Type in 2020
Table Antivirals Price by Type 2016-2020 (USD/Unit)
Table Global Antivirals Sales by Application (2016-2020) (K Units)
Table Global Antivirals Sales Share by Application (2016-2020)
Figure Global Sales Antivirals Market Share by Application (2016-2020)
Figure Global Sales Antivirals Market Share by Application (2016-2020)
Figure United States Antivirals Sales Growth Rate 2016-2020 (K Units)
Figure United States Antivirals Revenue Growth Rate 2016-2020 (Million US$)
Table United States Antivirals Sales by Company (2020) (K Units)
Table United States Antivirals Sales Market Share by Company (2020)
Figure United States Antivirals Sales Market Share by Company in 2020
Table United States Antivirals Sales by Type (2016-2020) (K Units)
Table United States Antivirals Sales Market Share by Type (2016-2020)
Figure United States Antivirals Market Share by Type in 2020
Table United States Antivirals Sales by Application (2016-2020) (K Units)
Table United States Antivirals Sales Market Share by Application (2016-2020)
Figure United States Antivirals Market Share by Application in 2020
Figure European Union Antivirals Sales Growth Rate 2016-2020 (K Units)
Figure European Union Antivirals Revenue Growth Rate 2016-2020 (Million US$)
Table European Union Antivirals Sales by Company (2020) (K Units)
Table European Union Antivirals Sales Market Share by Company (2020)
Figure European Union Antivirals Sales Market Share by Company in 2020
Table European Union Antivirals Sales by Type (2016-2020) (K Units)
Table European Union Antivirals Sales Market Share by Type (2016-2020)
Figure 2020 European Union Antivirals Market Share by Type
Table European Union Antivirals Sales by Application (2016-2020) (K Units)
Table European Union Antivirals Sales Market Share by Application (2016-2020)
Figure 2020 European Union Antivirals Market Share by Application
Figure China Antivirals Sales Growth Rate 2016-2020 (K Units)
Figure China Antivirals Revenue Growth Rate 2016-2020 (Million US$)
Table China Antivirals Sales by Company (2020) (K Units)
Table China Antivirals Sales Market Share by Company (2020)
Figure China Antivirals Sales Market Share by Company in 2020
Table China Antivirals Sales by Type (2016-2020) (K Units)
Table China Antivirals Sales Market Share by Type (2016-2020)
Figure China Antivirals Market Share by Type in 2020
Table China Antivirals Sales by Application (2016-2020) (K Units)
Table China Antivirals Sales Market Share by Application (2016-2020)
Figure China Antivirals Market Share by Application in 2020
Figure Rest of World Antivirals Sales Growth Rate 2016-2020 (K Units)
Figure Rest of World Antivirals Revenue Growth Rate 2016-2020 (Million US$)
Table Rest of World Antivirals Sales by Company (2020) (K Units)
Table Rest of World Antivirals Sales Market Share by Company (2020)
Figure Rest of World Antivirals Sales Market Share by Company in 2020
Table Rest of World Antivirals Sales by Type (2016-2020) (K Units)
Table Rest of World Antivirals Sales Market Share by Type (2016-2020)
Figure Rest of World Antivirals Market Share by Type in 2020
Table Rest of World Antivirals Sales by Application (2016-2020) (K Units)
Table Rest of World Antivirals Sales Market Share by Application (2016-2020)
Figure Rest of World Antivirals Market Share by Application in 2020
Table Rest of World Antivirals Sales by Countries (2016-2020) (K Units)
Table Rest of World Antivirals Sales Market Share by Countries (2016-2020)
Figure Rest of World Antivirals Sales Market Share by Countries in 2020
Table Rest of World Antivirals Revenue by Countries (2016-2020) (Million US$)
Table Rest of World Antivirals Revenue Market Share by Countries (2016-2020)
Figure Rest of World Antivirals Revenue Market Share by Countries in 2020
Figure Japan Antivirals Sales Growth Rate (2016-2020) (K Units)
Figure Japan Antivirals Revenue Growth Rate (2016-2020) (K Units)
Figure Korea Antivirals Sales Growth Rate (2016-2020) (K Units)
Figure Korea Antivirals Revenue Growth Rate (2016-2020) (K Units)
Figure India Antivirals Sales Growth Rate (2016-2020) (K Units)
Figure India Antivirals Revenue Growth Rate (2016-2020) (K Units)
Figure Southeast Asia Antivirals Sales Growth Rate (2016-2020) (K Units)
Figure Southeast Asia Antivirals Revenue Growth Rate (2016-2020) (K Units)
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2020)
Table Merck Antivirals Sales Growth Rate (2016-2020)
Table Merck Antivirals Sales Market Share in Global Market
Table Merck Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2020)
Table Johnson & Johnson Antivirals Sales Growth Rate (2016-2020)
Table Johnson & Johnson Antivirals Sales Market Share in Global Market
Table Johnson & Johnson Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Description and Business Overview
Table Teva Pharmaceutical Industries Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2020)
Table Teva Pharmaceutical Industries Antivirals Sales Growth Rate (2016-2020)
Table Teva Pharmaceutical Industries Antivirals Sales Market Share in Global Market
Table Teva Pharmaceutical Industries Recent Development
Table GSK Company Details
Table GSK Description and Business Overview
Table GSK Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2020)
Table GSK Antivirals Sales Growth Rate (2016-2020)
Table GSK Antivirals Sales Market Share in Global Market
Table GSK Recent Development
Table Mylan Company Details
Table Mylan Description and Business Overview
Table Mylan Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2020)
Table Mylan Antivirals Sales Growth Rate (2016-2020)
Table Mylan Antivirals Sales Market Share in Global Market
Table Mylan Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Description and Business Overview
Table Gilead Sciences Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2020)
Table Gilead Sciences Antivirals Sales Growth Rate (2016-2020)
Table Gilead Sciences Antivirals Sales Market Share in Global Market
Table Gilead Sciences Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Description and Business Overview
Table F. Hoffmann-La Roche Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2020)
Table F. Hoffmann-La Roche Antivirals Sales Growth Rate (2016-2020)
Table F. Hoffmann-La Roche Antivirals Sales Market Share in Global Market
Table F. Hoffmann-La Roche Recent Development
Table Bristol-Myers-Squibb Company Details
Table Bristol-Myers-Squibb Description and Business Overview
Table Bristol-Myers-Squibb Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2020)
Table Bristol-Myers-Squibb Antivirals Sales Growth Rate (2016-2020)
Table Bristol-Myers-Squibb Antivirals Sales Market Share in Global Market
Table Bristol-Myers-Squibb Recent Development
Table AbbVie Company Details
Table AbbVie Description and Business Overview
Table AbbVie Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2020)
Table AbbVie Antivirals Sales Growth Rate (2016-2020)
Table AbbVie Antivirals Sales Market Share in Global Market
Table AbbVie Recent Development
Table Aurobindo Pharma Company Details
Table Aurobindo Pharma Description and Business Overview
Table Aurobindo Pharma Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2020)
Table Aurobindo Pharma Antivirals Sales Growth Rate (2016-2020)
Table Aurobindo Pharma Antivirals Sales Market Share in Global Market
Table Aurobindo Pharma Recent Development
Table Cipla Company Details
Table Dr Reddy s Company Details
Figure Antivirals Value Chain
Table Antivirals Distributors List
Table Antivirals Customers List
Table Global Antivirals Sales Forecast 2021-2027 (K Units) & (Million US$)
Figure Global Antivirals Sales Forecast 2021-2027 (K Units)
Figure Global Antivirals Revenue Forecast 2021-2027 (Million US$)
Table Global Antivirals Sales Forecast by Type 2021-2027 (K Units)
Figure Global Antivirals Sales Forecast by Type 2021-2027 (K Units)
Figure Global Antivirals Sales Market Share Forecast by Type 2021-2027
Table Global Antivirals Sales Forecast by Application 2021-2027 (K Units)
Figure Global Antivirals Sales Forecast by Application 2021-2027 (K Units)
Figure Global Antivirals Sales Market Share Forecast by Application 2021-2027
Table Global Antivirals Sales Forecast by Regions 2021-2027 (K Units)
Figure Global Antivirals Sales Forecast by Regions 2021-2027 (K Units)
Figure Global Antivirals Sales Market Share Forecast by Regions 2021-2027
Table Global Antivirals Revenue Forecast by Regions 2021-2027 (K Units)
Figure Global Antivirals Revenue Forecast by Regions 2021-2027 (K Units)
Figure Global Antivirals Revenue Market Share Forecast by Regions 2021-2027
Figure United States Antivirals Sales Forecast 2021-2027 (K Units)
Figure United States Antivirals Revenue Forecast 2021-2027 (Million US$)
Figure European Union Antivirals Sales Forecast 2021-2027 (K Units)
Figure European Union Antivirals Revenue Forecast 2021-2027 (Million US$)
Figure China Antivirals Sales Forecast 2021-2027 (K Units)
Figure China Antivirals Revenue Forecast 2021-2027 (Million US$)
Figure Japan Antivirals Sales Forecast 2021-2027 (K Units)
Figure Japan Antivirals Revenue Forecast 2021-2027 (Million US$)
Figure Korea Antivirals Sales Forecast 2021-2027 (K Units)
Figure Korea Antivirals Revenue Forecast 2021-2027 (Million US$)
Figure India Antivirals Sales Forecast 2021-2027 (K Units)
Figure India Antivirals Revenue Forecast 2021-2027 (Million US$)
Figure Southeast Asia Antivirals Sales Forecast 2021-2027 (K Units)
Figure Southeast Asia Antivirals Revenue Forecast 2021-2027 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources